THIS FALL. IN TONIGHT’S WOMAN’S DOCTOR, RHEUMATOID ARTHRITIS IS AN AUTOIMMUNE DISEASE. IT’S AN INFLAMMATORY ARTHRITIS THAT OFTEN CAN PRESENT WITH A LOT OF JOINT PAIN, STIFFNESS, AND OFTEN IN YOUR ...

Any joint can become arthritic, but the most commonly affected areas of the body are the knees, hands, hips, feet and lower back - getty For many of us, aches and pains, sore joints and stiffness are ...

Dr. Beth Jonas answers the question: 'Anti-TNF Meds For Rheumatoid Arthritis?' — -- Question: What are anti-tumor necrosis factor (anti-TNF) medications and how are they used to treat rheumatoid ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

RA is an autoimmune disease where the immune system mistakenly attacks the lining of joints, causing inflammation and potential joint damage. Treatment goals for RA include reducing inflammation and ...

You may have felt great last week, but today your rheumatoid arthritis (RA) has flared, leaving your joints swollen, tender and sore. This is the unpredictable reality many people with rheumatoid ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 percent of American adults have some form of arthritis. And about 44 ...

Following the success of OpenAI's GPT series of large language models, an increasing number of institutions are proposing "foundation" models for artificial intelligence that, like GPT, are ...

Vagus nerve-mediated neuroimmune modulation by electrical stimulation using an implantable device was well-tolerated and had durable efficacy through 12-months in adults with rheumatoid arthritis, ...

A groundbreaking scientific perspective is reshaping how researchers understand rheumatoid arthritis, a debilitating autoimmune condition that affects nearly 1.3 million Americans. Recent studies have ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Mid-Stage Rheumatoid Arthritis Trial With AZD1163 ...